Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 21 |
NetGPI | no | yes: 0, no: 21 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 10 |
GO:0110165 | cellular anatomical entity | 1 | 10 |
GO:0043226 | organelle | 2 | 4 |
GO:0043227 | membrane-bounded organelle | 3 | 4 |
GO:0043229 | intracellular organelle | 3 | 4 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 4 |
Related structures:
AlphaFold database: A0A3S7X4C9
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 4 |
GO:0020037 | heme binding | 4 | 4 |
GO:0046906 | tetrapyrrole binding | 3 | 4 |
GO:0097159 | organic cyclic compound binding | 2 | 4 |
GO:1901363 | heterocyclic compound binding | 2 | 4 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 73 | 75 | PF00675 | 0.413 |
CLV_PCSK_KEX2_1 | 73 | 75 | PF00082 | 0.429 |
DOC_MAPK_DCC_7 | 14 | 24 | PF00069 | 0.485 |
DOC_USP7_MATH_1 | 109 | 113 | PF00917 | 0.266 |
DOC_USP7_MATH_1 | 51 | 55 | PF00917 | 0.551 |
LIG_14-3-3_CanoR_1 | 10 | 14 | PF00244 | 0.524 |
LIG_14-3-3_CanoR_1 | 52 | 60 | PF00244 | 0.434 |
LIG_Clathr_ClatBox_1 | 19 | 23 | PF01394 | 0.504 |
LIG_FHA_1 | 112 | 118 | PF00498 | 0.278 |
LIG_LIR_Apic_2 | 16 | 21 | PF02991 | 0.547 |
LIG_LIR_Gen_1 | 93 | 104 | PF02991 | 0.623 |
LIG_NRP_CendR_1 | 120 | 121 | PF00754 | 0.594 |
LIG_PCNA_yPIPBox_3 | 27 | 40 | PF02747 | 0.412 |
LIG_PTB_Apo_2 | 12 | 19 | PF02174 | 0.500 |
LIG_PTB_Phospho_1 | 12 | 18 | PF10480 | 0.500 |
LIG_SH2_GRB2like | 39 | 42 | PF00017 | 0.488 |
LIG_SH2_STAP1 | 96 | 100 | PF00017 | 0.623 |
LIG_SH2_STAT3 | 39 | 42 | PF00017 | 0.437 |
LIG_SH2_STAT5 | 18 | 21 | PF00017 | 0.493 |
LIG_SH2_STAT5 | 39 | 42 | PF00017 | 0.437 |
LIG_SH3_2 | 69 | 74 | PF14604 | 0.610 |
LIG_SH3_3 | 66 | 72 | PF00018 | 0.593 |
MOD_GlcNHglycan | 111 | 114 | PF01048 | 0.226 |
MOD_GlcNHglycan | 78 | 81 | PF01048 | 0.498 |
MOD_GSK3_1 | 76 | 83 | PF00069 | 0.653 |
MOD_GSK3_1 | 9 | 16 | PF00069 | 0.529 |
MOD_PIKK_1 | 42 | 48 | PF00454 | 0.498 |
MOD_PKA_2 | 51 | 57 | PF00069 | 0.434 |
MOD_PKA_2 | 9 | 15 | PF00069 | 0.532 |
TRG_ENDOCYTIC_2 | 96 | 99 | PF00928 | 0.596 |
TRG_ER_diArg_1 | 72 | 74 | PF00400 | 0.620 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3Q8ICI2 | Leishmania donovani | 28% | 100% |
A0A3Q8ILC3 | Leishmania donovani | 31% | 100% |
A0A3S7WPP2 | Leishmania donovani | 32% | 100% |
A4H4U1 | Leishmania braziliensis | 34% | 100% |
A4HJ97 | Leishmania braziliensis | 78% | 100% |
A4HJ98 | Leishmania braziliensis | 30% | 100% |
A4HJA2 | Leishmania braziliensis | 37% | 100% |
A4HT20 | Leishmania infantum | 32% | 100% |
A4I6P2 | Leishmania infantum | 100% | 100% |
A4I6P3 | Leishmania infantum | 28% | 100% |
E9ACS1 | Leishmania major | 36% | 100% |
E9AGY1 | Leishmania infantum | 31% | 100% |
E9AL09 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 30% | 100% |
E9AVI6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 30% | 100% |
E9B1R4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 87% | 99% |
E9B1R5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 29% | 100% |
E9B1R7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 34% | 100% |
Q4Q6E4 | Leishmania major | 34% | 100% |
Q4Q6E6 | Leishmania major | 28% | 100% |
Q4QIU6 | Leishmania major | 28% | 100% |